Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
30 Jun, 2026, 10.47 AM IST
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announcedDivi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751...
23 May, 2026, 01.51 PM IST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
20 May, 2026, 12.05 PM IST
Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?Divi's Laboratories reported a strong Q4FY25, with a 26% YoY increase in net profit to Rs 667 crore and a 12.26% rise in revenue to Rs 2,53...
19 May, 2025, 09.22 AM IST
Divi’s Labs Q4 Results: Cons PAT slumps 64% YoY to Rs 321 crore; Rs 30/share dividend declaredOperating profit, calculated as earnings before interest, taxes, depreciation and amortization (EBITDA), plunged 56% YoY to Rs 488 crore in...
20 May, 2023, 01.52 PM IST
Divi's Labs shares fall for 5th day, tank over 4%The company's total revenue dipped 3.6% YoY to Rs 1,935 crore for the quarter ended September 30 as against a consolidated total income of ...
09 Nov, 2022, 01.26 PM IST
Divi’s Labs Q4 Results: Profit surges 78% YoY to Rs 895 crore, beats estimatesThe Board of Directors of the company has recommended a dividend of Rs 30 per share for the financial year 2021-22, subject to approval of ...
24 May, 2022, 10.23 AM IST
Divi’s Lab top pharma bet for Neeraj DewanDivi’s Lab has been performing very well and it will continue to do well."
09 Jun, 2021, 12.26 PM IST
Divi’s Labs hits all-time high after robust Q2 resultsA recent entrant to the Nifty pack, Divi’s Labs is up 82 per cent year-to-date, and has almost doubled over the last one year.
09 Nov, 2020, 01.14 PM IST
Divi’s Labs Q2 preview: Firm to maintain momentum, PAT to grow in double digitsDivi’s Labs has been one of the best performing pharma companies this year, as far as market returns are concerned.
06 Nov, 2020, 11.15 PM IST
- Divi’s Lab can climb to levels closer to 1160: Prakash Gaba
Divi’s Lab can climb to levels closer to 1160, stop below 1100 zones.
12 Nov, 2013, 12.28 PM IST
- Buy Divi’s Lab with target price of Rs 985: Mitesh Thacker
Buy Divi’s Lab at a stop of Rs 969.
21 Jun, 2013, 11.04 AM IST
- Buy Divi’s Lab with a target price of Rs 1086: Mitesh Thacker
" Divi’s Lab is a buy call with a target price of Rs 1086 and a stop loss of Rs 1048."
20 Feb, 2013, 10.40 AM IST
- Sell Divi’s Lab with target of 1120: Mitesh Thacker
Divi’s Lab is a ‘Sell’ call with a target of Rs 1120 and a stop loss of Rs 1172.
07 Dec, 2012, 10.52 AM IST
- Buy Divi’s Lab with a target of Rs 1230: Sandeep Wagle
"I am buying Divi’s Lab, stop loss 1175, target 1230. Divi’s Labs has not moved that much, there is more scope for upside move."
12 Nov, 2012, 03.45 PM IST
- Buy Divi’s Labs with a stop loss of Rs 1165: Deepak Mohoni
Divi’s Labs is a 'BUY' call with a target of Rs 1234 and a stop loss of Rs 1165
31 Oct, 2012, 12.06 PM IST